Novaliq Targeting Phenotypes in Dry Eye Disease Interview at OIS@ASCRS 2019

Allergan’s Pipeline Busy in Anterior and Posterior Interview at OIS@ASCRS 2019Подробнее

Novaliq | NovaTears® in Dry Eye Disease - Mode of actionПодробнее

TearClear Delivering Preservative-Free Drugs Interview at OIS@ASCRS 2019Подробнее

Novaliq GmbH - Innovation Showcase at Ophthalmology Innovation Summit @ ASCRS 2019Подробнее

Novaliq Takes Challenge to Water-Based DropsПодробнее

Novaliq GmbH - Dry Eye Breakout at OIS @ AAO 2019Подробнее

Novaliq Goes After Dry Eye DiseaseПодробнее

CEO Roesky Sees Dry Eye Challenges as Opportunities for NovaliqПодробнее

Sight Sciences ASCRS 2024 TearCare UpdateПодробнее

Novartis Has a Wide-ranging Pipeline Interview at Ophthalmology Innovation Summit @ ASCRS 2019Подробнее

iVeena Delivery Systems - OIS@ASCRS (2018)Подробнее

ASCRS 2020: Evaluation of intraoperative use of DEXYCU on signs/symptoms of dry eyeПодробнее

Industry Spotlight | Novaliq | Ocular Surface Academy | Healthcare | Dry eyesПодробнее

Olympic Ophthalmics - Dry Eye Breakout at OIS @ AAO 2019Подробнее

Novaliq Set to `Transform Ocular Therapies’Подробнее

Novaliq - Christian Roesky, PHD, CEOПодробнее

ASCRS 2020: Evolution of an administration technique for DEXYCUПодробнее